Robert Kralovics
Overview
Explore the profile of Robert Kralovics including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
7259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jager R, Hoke M, Mayer F, Boden S, Englisch C, Ay C, et al.
J Am Coll Cardiol
. 2024 May;
83(18):1717-1727.
PMID: 38692825
Background: The expansion of hematopoietic stem cells caused by acquired somatic mutations (clonal hematopoiesis [CH]) is a novel cardiovascular risk factor. The prognostic value of CH in patients with carotid...
2.
Borsani O, Jager R, Pietra D, Flieder I, Riccaboni G, Kralovics R, et al.
Haematologica
. 2024 Apr;
109(8):2738-2740.
PMID: 38654656
No abstract available.
3.
Jager R, Geyer S, Kavirayani A, Kiss M, Waltenberger E, Rulicke T, et al.
Microsc Res Tech
. 2023 Dec;
87(4):854-866.
PMID: 38115643
Genetically engineered mouse models have the potential to unravel fundamental biological processes and provide mechanistic insights into the pathogenesis of human diseases. We have previously observed that germline genetic variation...
4.
Gisslinger H, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, et al.
Leukemia
. 2023 Aug;
37(10):2129-2132.
PMID: 37634011
No abstract available.
5.
Ivanov D, Milosevic Feenstra J, Sadovnik I, Herrmann H, Peter B, Willmann M, et al.
Am J Hematol
. 2023 Feb;
98(5):770-783.
PMID: 36814396
Myeloproliferative neoplasms (MPN) are characterized by uncontrolled expansion of myeloid cells, disease-related mutations in certain driver-genes including JAK2, CALR, and MPL, and a substantial risk to progress to secondary acute...
6.
Pecquet C, Papadopoulos N, Balligand T, Chachoua I, Tisserand A, Vertenoeil G, et al.
Blood
. 2022 Nov;
141(8):917-929.
PMID: 36356299
Mutant calreticulin (CALR) proteins resulting from a -1/+2 frameshifting mutation of the CALR exon 9 carry a novel C-terminal amino acid sequence and drive the development of myeloproliferative neoplasms (MPNs)....
7.
Luque Paz D, Kralovics R, Skoda R
Blood
. 2022 Nov;
141(16):1909-1921.
PMID: 36347013
BCR::ABL1-negative myeloproliferative neoplasms (MPNs) are clonal diseases originating from a single hematopoietic stem cell that cause excessive production of mature blood cells. The 3 subtypes, that is, polycythemia vera (PV),...
8.
Schueller C, Majoros A, Nivarthi H, Kralovics R
Am J Hematol
. 2022 Sep;
97(11):E396-E399.
PMID: 36053947
No abstract available.
9.
Kiladjian J, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, et al.
Leukemia
. 2022 Feb;
36(5):1408-1411.
PMID: 35210530
No abstract available.
10.
Milosevic Feenstra J, Jager R, Schischlik F, Ivanov D, Eisenwort G, Rumi E, et al.
Am J Hematol
. 2022 Jan;
97(4):390-400.
PMID: 35015307
Myeloproliferative neoplasms (MPN) are chronic stem cell disorders characterized by enhanced proliferation of myeloid cells, immune deregulation, and drug resistance. JAK2 somatic mutations drive the disease in 50-60% and CALR...